| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TUBERCULOSIS |
1 Department of Epidemiology, Local Health Agency RME, Rome, Italy
2 Department of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, London, UK
Correspondence to:
Correspondence to:
Dr A Faustini
Department of Epidemiology, RME, 00198 Rome, Italy; faustini{at}asplazio.it
Background: The resurgence of tuberculosis (TB) in western countries has been attributed to the HIV epidemic, immigration, and drug resistance. Multidrug resistant tuberculosis (MDR-TB) is caused by the transmission of multidrug resistant Mycobacterium tuberculosis strains in new cases, or by the selection of single drug resistant strains induced by previous treatment. The aim of this report is to determine risk factors for MDR-TB in Europe.
Methods: A systematic review was conducted of published reports of risk factors associated with MDR-TB in Europe. Meta-analysis, meta-regression, and sub-grouping were used to pool risk estimates of MDR-TB and to analyse associations with age, sex, immigrant status, HIV status, occurrence year, study design, and area of Europe.
Results: Twenty nine papers were eligible for the review from 123 identified in the search. The pooled risk of MDR-TB was 10.23 times higher in previously treated than in never treated cases, with wide heterogeneity between studies. Study design and geographical area were associated with MDR-TB risk estimates in previously treated patients; the risk estimates were higher in cohort studies carried out in western Europe (RR 12.63; 95% CI 8.20 to 19.45) than in eastern Europe (RR 8.53; 95% CI 6.57 to 11.06). National estimates were possible for six countries. MDR-TB cases were more likely to be foreign born (odds ratio (OR) 2.46; 95% CI 1.86 to 3.24), younger than 65 years (OR 2.53; 95% CI 1.74 to 4.83), male (OR 1.38; 95% CI 1.16 to 1.65), and HIV positive (OR 3.52; 95% CI 2.48 to 5.01).
Conclusions: Previous treatment was the strongest determinant of MDR-TB in Europe. Detailed study of the reasons for inadequate treatment could improve control strategies. The risk of MDR-TB in foreign born people needs to be re-evaluated, taking into account any previous treatment.
Abbreviations: MDR-TB, multidrug resistant tuberculosis
Keywords: tuberculosis; multidrug resistance; risk factors; systematic review; meta-analysis
This article has been cited by other articles:
|
|
 |
|
  C. E. French, J. R. Glynn, M. E. Kruijshaar, I. C. Ditah, V. Delpech, and I. Abubakar The association between HIV and antituberculosis drug resistance Eur. Respir. J., September 1, 2008; 32(3): 718 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Cohen, C. Colijn, A. Wright, M. Zignol, A. Pym, and M. Murray Challenges in Estimating the Total Burden of Drug-resistant Tuberculosis Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1302 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E Kruijshaar, J. M Watson, F. Drobniewski, C. Anderson, T. J Brown, J. G Magee, E G. Smith, A. Story, and I. Abubakar Increasing antituberculosis drug resistance in the United Kingdom: analysis of national surveillance data BMJ, May 31, 2008; 336(7655): 1231 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A C. Tanrikulu, S. Hosoglu, T. Ozekinci, A. Abakay, and F. Gurkan Risk factors for drug resistant tuberculosis in southeast Turkey Trop Doct, April 1, 2008; 38(2): 91 - 93. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
